ARTICLE | Company News

Leica Microsystems, Abbott deal

July 26, 2010 7:00 AM UTC

Leica will use Abbott's fluorescence in situ hybridization (FISH) probes that target the EGFR 2 ( HER2; ErbB2; neu) gene locus to develop a fully automated version of Abbott's PathVysion FISH assay for use on the Leica Microsystems' BOND staining platform. The test will be used to identify patients who are likely to respond to Herceptin trastuzumab. ...